Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin
Benedetta Colmegna(Mario Negri Institute for Pharmacological Research), Maurizio D’Incalci(Humanitas University)
Cited by 43
Related Papers
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
|The Lancet Oncology|2011|178
Trabectedin for Women With Ovarian Carcinoma After Treatment With Platinum and Taxanes Fails
|Journal of Clinical Oncology|2005|164
Inhibition of tumor‐associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti‐PD‐1 therapy
|European Journal of Immunology|2021|35